
Milestone Scientific MLSS
$ 0.34
-1.02%
Quarterly report 2026-Q1
added 05-13-2026
Milestone Scientific Total Shareholders Equity 2011-2026 | MLSS
Annual Total Shareholders Equity Milestone Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.81 M | 5.83 M | 8.01 M | 10.2 M | 16.4 M | 16.2 M | 1.7 M | 1.54 M | 7.24 M | 8.5 M | 10.3 M | 14.6 M | 5.52 M | 1.94 M | 1.94 M | 2.33 M | 2.64 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.4 M | 1.54 M | 6.93 M |
Quarterly Total Shareholders Equity Milestone Scientific
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.28 M | 2.55 M | 3.34 M | 4.46 M | 5.83 M | 7.22 M | 7.95 M | 7.46 M | 8.01 M | 6.99 M | 7.7 M | 9.25 M | 10.2 M | 11.2 M | 12.7 M | 14.8 M | 16.4 M | 16 M | 17.6 M | 19 M | 16.2 M | 16.2 M | 16.2 M | 16.2 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.54 M | 1.54 M | 1.54 M | 1.54 M | 7.24 M | 7.24 M | 7.24 M | 7.24 M | 8.5 M | 8.5 M | 8.5 M | 8.5 M | 10.3 M | 10.3 M | 10.3 M | 10.3 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | 5.52 M | 5.52 M | 5.52 M | 5.52 M | 1.94 M | 1.94 M | 1.94 M | 1.94 M | 1.94 M | 1.94 M | 1.94 M | 1.94 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 19 M | 1.54 M | 7.82 M |
Total Shareholders Equity of other stocks in the Medical instruments industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
The Cooper Companies
COO
|
8.24 B | $ 60.84 | 0.76 % | $ 12.1 B | ||
|
Atrion Corporation
ATRI
|
243 K | - | - | $ 810 M | ||
|
ICU Medical
ICUI
|
2.12 B | $ 122.4 | -0.48 % | $ 3.02 B | ||
|
iRhythm Technologies
IRTC
|
153 M | $ 114.08 | -0.07 % | $ 3.65 B | ||
|
Intuitive Surgical
ISRG
|
17.8 B | $ 428.24 | 0.04 % | $ 153 B | ||
|
Alcon
ALC
|
18.8 B | $ 64.65 | 1.02 % | $ 40.4 B | ||
|
Repro Med Systems
KRMD
|
17 M | $ 3.91 | -1.75 % | $ 181 M | ||
|
LeMaitre Vascular
LMAT
|
394 M | $ 99.4 | -0.1 % | $ 2.25 B | ||
|
Masimo Corporation
MASI
|
1.05 B | $ 178.41 | 0.03 % | $ 9.51 B | ||
|
Ekso Bionics Holdings
EKSO
|
9.03 M | - | - | $ 28.6 M | ||
|
Envista Holdings Corporation
NVST
|
3.11 B | $ 23.9 | 0.21 % | $ 4.02 B | ||
|
electroCore
ECOR
|
-1.71 M | $ 6.3 | -2.02 % | $ 53.4 K | ||
|
Haemonetics Corporation
HAE
|
821 M | $ 57.35 | 0.46 % | $ 2.89 B | ||
|
Isoray
ISR
|
207 M | - | 0.03 % | $ 108 M | ||
|
Glaukos Corporation
GKOS
|
462 M | $ 143.0 | 0.6 % | $ 6.93 B | ||
|
STAAR Surgical Company
STAA
|
344 M | $ 31.91 | -0.31 % | $ 1.58 B | ||
|
STERIS plc
STE
|
6.6 B | $ 216.15 | 0.08 % | $ 21.3 B | ||
|
Teleflex Incorporated
TFX
|
3.12 B | $ 130.56 | 0.21 % | $ 5.83 B | ||
|
InfuSystem Holdings
INFU
|
57.3 M | $ 8.43 | -2.37 % | $ 174 M | ||
|
Microbot Medical
MBOT
|
77.6 M | $ 1.92 | 3.69 % | $ 87.9 M | ||
|
Merit Medical Systems
MMSI
|
1.58 B | $ 62.37 | -0.3 % | $ 3.69 B | ||
|
Utah Medical Products
UTMD
|
119 M | $ 63.24 | -0.72 % | $ 205 M | ||
|
West Pharmaceutical Services
WST
|
3.18 B | $ 301.21 | 0.34 % | $ 21.8 B | ||
|
Pulse Biosciences
PLSE
|
80.7 M | $ 25.45 | -6.09 % | $ 1.72 B | ||
|
DENTSPLY SIRONA
XRAY
|
1.34 B | $ 10.1 | -3.03 % | $ 2.01 B | ||
|
Retractable Technologies
RVP
|
74.4 M | $ 0.69 | -0.01 % | $ 20.7 M | ||
|
Pro-Dex
PDEX
|
36.6 M | $ 57.73 | -1.57 % | $ 190 M | ||
|
Predictive Oncology
POAI
|
47.7 M | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
372 M | $ 20.76 | -1.42 % | $ 991 M | ||
|
Stereotaxis
STXS
|
13.5 M | $ 1.89 | -2.83 % | $ 172 M | ||
|
Baxter International
BAX
|
6.13 B | $ 17.62 | -0.96 % | $ 9.04 B | ||
|
ResMed
RMD
|
3.36 B | $ 204.91 | 1.21 % | $ 29.9 B | ||
|
AtriCure
ATRC
|
492 M | $ 28.69 | 1.92 % | $ 1.37 B | ||
|
Harvard Bioscience
HBIO
|
13.7 M | $ 5.34 | -3.26 % | $ 237 M | ||
|
NeuroMetrix
NURO
|
14.3 M | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
183 M | $ 10.98 | -0.45 % | $ 449 M | ||
|
Becton, Dickinson and Company
BDX
|
25.4 B | $ 143.99 | -0.33 % | $ 41.4 B | ||
|
Nephros
NEPH
|
10.2 M | $ 3.2 | -4.23 % | $ 34 M | ||
|
OraSure Technologies
OSUR
|
341 M | $ 3.04 | 3.05 % | $ 223 M | ||
|
Repligen Corporation
RGEN
|
2.11 B | $ 106.8 | 3.31 % | $ 6.01 M |